2013 Annual Report on Prostate Diseases
Most men eventually develop some type of prostate problem, and 
when  they do there are usually no easy solutions. The three most common
  prostate problems are benign prostatic hyperplasia (BPH), prostatitis,
  and prostate cancer. Men with the same condition and symptoms might 
opt  for very different treatments — or choose to do nothing at all.
A number of exciting new treatment options have emerged for prostate diseases, including new medications and refined surgical techniques. But daunting challenges remain. A major disappointment has been in the area of chemoprevention — an approach that uses drugs or supplements to try to reduce risk of prostate cancer. Two leading contenders — 5-alpha reductase inhibitors and vitamin E supplements — not only don’t seem to prevent prostate cancer but actually may increase risk of developing it. And in a major development, the U.S. Preventive Services Task Force has recommended against routine prostate-specific antigen (PSA) screening — arguing that for most men screening does not save lives and causes more harm than benefit.
That’s why this unique publication is more than a primer on prostate conditions; it includes roundtable discussions with experts at the forefront of prostate research, interviews with patients about their treatment decisions, and the latest thinking on complementary therapies.
The goal of this publication is not to relate easy answers. Rather, our mission is to provide you with the information you need to understand the current controversies, avoid common pitfalls, and work with your doctor to make informed choices about your prostate health.
Prepared by the editors of Harvard Health Publications in consultation with Marc B. Garnick, M.D., Clinical Professor of Medicine, Harvard Medical School, and Hematology/Oncology Division, Beth Israel Deaconess Medical Center. 136 pages. (2013)
A number of exciting new treatment options have emerged for prostate diseases, including new medications and refined surgical techniques. But daunting challenges remain. A major disappointment has been in the area of chemoprevention — an approach that uses drugs or supplements to try to reduce risk of prostate cancer. Two leading contenders — 5-alpha reductase inhibitors and vitamin E supplements — not only don’t seem to prevent prostate cancer but actually may increase risk of developing it. And in a major development, the U.S. Preventive Services Task Force has recommended against routine prostate-specific antigen (PSA) screening — arguing that for most men screening does not save lives and causes more harm than benefit.
That’s why this unique publication is more than a primer on prostate conditions; it includes roundtable discussions with experts at the forefront of prostate research, interviews with patients about their treatment decisions, and the latest thinking on complementary therapies.
The goal of this publication is not to relate easy answers. Rather, our mission is to provide you with the information you need to understand the current controversies, avoid common pitfalls, and work with your doctor to make informed choices about your prostate health.
Prepared by the editors of Harvard Health Publications in consultation with Marc B. Garnick, M.D., Clinical Professor of Medicine, Harvard Medical School, and Hematology/Oncology Division, Beth Israel Deaconess Medical Center. 136 pages. (2013)
More Like This
What to do about Erectile Dysfunction
With all the ads on TV and in magazines 
heralding pills to treat erectile dysfunction (ED), it’s tempting to 
think that treatment for ED begins and ends with Viagra, Levitra, and 
Cialis. But it’s important to be aware that many men can ease, or even 
reverse, ED by making simple lifestyle changes — such as losing excess 
weight and quitting smoking — that also are likely to boost their 
overall health and reduce their chances of developing diabetes, 
cardiovascular disease, and metabolic syndrome. This report offers a 
comprehensive review of these treatments, as well as the causes of 
erectile dysfunction and how ED may be an early warning sign for other 
serious health problems.
Learn more »
Learn more »
A Guide to Men's Health Fifty and Forward
A Guide to Men’s Health Fifty and Forward,
 this Special Health  Report offers steps and strategies to  lessen — or
 prevent — threats to your well-being and longevity. It  provides a 
wide-ranging, clear-eyed look at the leading causes of death  for men at
 midlife and beyond. It examines those factors that put you at  risk for
 a variety of problems and explains the important measures you  can take
 to reduce those risks.
Learn more »
Learn more »
No comments:
Post a Comment